Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences

The global pandemic of COVID-19 has attracted extensive drug searching interets for the new coronavirus SARS-CoV-2. Although currently several of clinically used “old” drugs have been repurposed to this new disease for the urgent clinical investigation, there is still great demand for more effective...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Biomed
Главные авторы: Wang, Aoli, Sun, Yong, Liu, Qingwang, Wu, Hong, Liu, Juan, He, Jun, Yu, Junling, Chen, Qing Qing, Ge, Yinglu, Zhang, Zhuhui, Hu, Chen, Chen, Cheng, Qi, Ziping, Zou, Fengming, Liu, Feiyang, Hu, Jie, Zhao, Ming, Huang, Tao, Wang, Beilei, Wang, Li, Wang, Wei, Wang, Wenchao, Ren, Tao, Liu, Jing, Sun, Yehuan, Fan, Song, Wu, Qibing, Liang, Chaozhao, Sun, Liangdan, Su, Bin, Wei, Wei, Liu, Qingsong
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Singapore 2020
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7700809/
https://ncbi.nlm.nih.gov/pubmed/34765997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s43556-020-00018-9
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы